Please find attached signed Annual Secretarial Compliance report for the year ended March 31, 2026
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Procter & Gamble Health Limited has filed its annual secretarial compliance report for FY2026, reviewed by Dholakia & Associates LLP. The company was found largely compliant with SEBI regulations including LODR, insider trading, and related party transaction norms. Two minor deviations were noted: (1) the company failed to intimate stock exchanges about the appointment of Mr. Shashank Srowthy as Executive Director via postal ballot, and (2) a one-day delay in filing debt securities disclosures in the previous year. Management acknowledged both lapses and committed to strengthening compliance monitoring. No monetary penalties were imposed, and no actions were taken by SEBI or stock exchanges against the company.
The filing reveals administrative compliance gaps rather than material violations. The company has taken corrective action, and no penalties were levied, suggesting minimal impact on shareholder value or stock price. However, investors should note the need for improved disclosure timeliness.